American International Group, Inc. Cidara Therapeutics, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$1.87 - $2.7 $39,268 - $56,697	-20,999 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$2.06 - $3.01 $115 - $168	56 Added 0.27%	20,999 $56,000
Q4 2020 Feb 12, 2021	SELL	$1.99 - $3.25 $240 - $393	-121 Reduced 0.57%	20,943 $42,000
Q3 2020 Nov 04, 2020	BUY	$2.85 - $4.1 $1,809 - $2,603	635 Added 3.11%	21,064 $60,000
Q2 2020 Aug 12, 2020	BUY	$2.39 - $4.0 $48,825 - $81,716	20,429 New	20,429 $75,000

22.1M

2.7K

100

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $837M
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.